Skip to main content
Frank Haluska, MD, Oncology, Boston, MA

FrankG.HaluskaMD

Oncology Boston, MA

Physician

Are you Dr. Haluska?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 52 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Frank Haluska, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1991 - 1995
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1989 - 1991
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1989

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1991 - 2025

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Anchiano Appoints Steve DiPalma as Chief Financial Officer
    Anchiano Appoints Steve DiPalma as Chief Financial OfficerMay 5th, 2020
  • Anchiano Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
    Anchiano Therapeutics to Present at the Ladenburg Thalmann Healthcare ConferenceSeptember 20th, 2019
  • Anchiano Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment Conference
    Anchiano Therapeutics to Present at the H.C. Wainwright 20th Annual Global Investment ConferenceSeptember 3rd, 2019
  • Join now to see all

Grant Support

  • Genetics Of RAS, PTEN, BRAF And CDKN2A In MelanomaNational Cancer Institute2006
  • Genetics Of RAS, PTEN, BRAF And CDKN2A In MelanomaNational Cancer Institute2005
  • Peptide-Pulsed Dendritic Cell Therapy For MelanomaNational Cancer Institute1999–2000